Factors contributing to trends in prescription drug expenditures

Clinical Therapeutics

Volumn 21, Issue 7, 1999, Pages 1241-1253

  Suh, Dong Churl ^a   Lacy, Clifton R ^b   Barone, Joseph A ^a   Moylan, Deana ^a   Kostis, John B ^b  

^a RUTGERS UNIVERSITY   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Contributing factors; Drug expenditures; Medicaid drug expenditures; Prescription drugs

Indexed keywords

ARTICLE; DRUG COST; ECONOMIC ASPECT; HEALTH CARE COST; HEALTH CARE POLICY; MEDICAID; POPULATION GROWTH; PRESCRIPTION;

EID: 0032812018     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(00)80026-0     Document Type: Article

References (34)

1. 1. Levit KR, Sensenig AL, Cowan CA, Lazenby HC. National health care expenditures, 1995. Health Care Financ Rev. 1995;18:175-214.
2. 2. Health Care Financing Administration. National health expenditures projections through 2030. Health Care Financ Rev. 1992;14:1-29.
3. 3. Warshawsky M. Projection of health care expenditures as a share of the GDP: Actuarial and macroeconomic approaches. Health Serv Res. 1994;29:293-313.
4. 4. Shorb GS. The rising cost of pharmaceuticals: A hospital executive's perspective. Am J Hosp Pharm. 1993;50(Suppl 4):S4-S6.
5. 5. Ryan BA. The rising cost of pharmaceuticals: An industry observer's perspective. Am J Hosp Pharm. 1993;50(Suppl 4):S3-S4.
6. 6. Mehl B, Santell JP. Projecting future drug expenditures - 1998. Am J Health-Syst Pharm. 1998;55:127-138.
7. 7. Freeland MS, Schendler CE. National health expenditures: Short-term outlook and long-term projections. Health Care Financ Rev. 1981;3:97-126.
8. 8. Arnett RH, McKusick DR, Sonnefeld ST. Projections of health care spending to 1990. Health Care Financ Rev. 1986;7:1-35.
9. 9. Council of Economic Advisors. Economic Report of the President. Washington, DC: US Government Printing Office; 1997.
10. 10. Letsch SW. National health care spending in 1991. Health Aff. 1993;12:94-110.
11. 11. Levit KR, Cowan CA, Lazenby HC. National health spending trends, 1960-1993. Health Aff. 1994;13:14-31.
12. 12. Tudor C. Medicaid expenditures and state responses. Health Care Financ Rev. 1995; 16:1-10.
13. 13. Health Care Financing Administration. State and federal Medicaid expenditures: 1975-94. Health Care Financ Rev. 1996; 18(Statistical Suppl):176-185.
14. 14. Health Care Financing Administration. Overview of the Medicare and Medicaíd programs. Health Care Financ Rev. 1997; 19(Statistical Suppl):1-17.
15. 15. Levit KR, Lazenby HC, Sivarajan L. Health care spending in 1994: Slowest in decades. Health Aff. 1996;15:130-144.
16. 16. Smith S, Freeland M, Hefeler S, McKusick D. The next ten years of health spending: What does the future hold? Health Aff. 1998;17:128-140.
17. 17. Schondelmeyer SW, Thomas J III. Trends in retail prescription expenditures. Health Aff. 1990;9:131-145.
18. 18. Pub L No. 101-508, 104 Stat 1388, 1990.
19. 19. Changes in Drug Prices Paid by HMOs and Hospitals Since Enactment of Rebate Provisions. Washington, DC: US General Accounting Office; 1993.
20. 20. Newhouse JP. Medical care costs. How much welfare loss? J Econ Perspect. 1992;6:3-21.
21. 21. Newhouse JP. An iconoclastic view of health cost containment. Health Aff. 1993; 12(Suppl):152-171.
22. 22. Sensenig AL, Heffler SK, Donham CS. Health care indicators. Health Care Financ Rev. 1995;17:277-287.
23. 23. Kleiman E. The determinants of national outlay on health. In: Perlman M, ed. The Economics of Health and Medical Care. San Francisco: Dellen Publishing; 1974.
24. 24. Getzen T. Population aging and the growth of health expenditures. J Gerontol. 1992; 47(Suppl):S98-S104.
25. 25. Mendelson DN, Schwartz WB. The effects of aging and population growth on health care costs. Health Aff. 1993;12:119-124.
26. 26. Plotter J. Comprehensive geriatric assessment in the outpatient setting: Population characteristics and factors influencing outcome. Exp Gerontol. 1993;28:447-457.
27. 27. Schwartz WB. The inevitable failure of current cost strategies. JAMA. 1987;257: 220-224.
28. 28. Thorne LM. An analysis of rising health care costs. Gastroenterol Nursing. 1992; 14:174-178.
29. 29. Rettig RA. Medical innovation duels cost containment. Health Aff. 1994;13:7-27.
30. 30. Gerdtham U-G, Johannesson M, Gunnarsson B, Marcusson M. The effect of changes in treatment patterns on drug expenditures. Pharmacoeconomics. 1998;13:127-134.
31. 31. Newhouse JP. Has the erosion of the medical marketplace ended? J Health Polit Policy Law. 1988;13:263-278.
32. 32. Peden EA, Freeland MS. A historical analysis of medical spending growth, 1960-1993. Health Aff. 1995;14:235-247.
33. 33. Schondelmeyer SW. Pricing trends in the pharmaceutical industry. Paper presented at: International Business Communications USA Conference; 1991; Washington, DC.
34. 34. Gianfrancesco F, Baines A, Richard D. Utilization effects of prescription drug benefits in an aging population. Health Care Financ Rev. 1994;15:113-126.